{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:07:19Z","timestamp":1792076839210,"version":"4.4.0"},"reference-count":81,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100010570","name":"Ministry for Science and Culture of Lower Saxony","doi-asserted-by":"publisher","award":["14-76103-184"],"award-info":[{"award-number":["14-76103-184"]}],"id":[{"id":"10.13039\/501100010570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010570","name":"Ministry for Science and Culture of Lower Saxony","doi-asserted-by":"publisher","award":["MWK HZI COVID-19"],"award-info":[{"award-number":["MWK HZI COVID-19"]}],"id":[{"id":"10.13039\/501100010570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["345803"],"award-info":[{"award-number":["345803"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["340141"],"award-info":[{"award-number":["340141"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KI2006D"],"award-info":[{"award-number":["01KI2006D"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KI20328A"],"award-info":[{"award-number":["01KI20328A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KX2021"],"award-info":[{"award-number":["01KX2021"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PO 716\/11-1"],"award-info":[{"award-number":["PO 716\/11-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PO 716\/14-1"],"award-info":[{"award-number":["PO 716\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI114776"],"award-info":[{"award-number":["AI114776"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015691","name":"HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI151698"],"award-info":[{"award-number":["AI151698"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009559","name":"Life Sciences Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009559","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001906","name":"Washington Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001906","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2022,10,26]]},"abstract":"<jats:p>Imagine a future viral pandemic where if you test positive for the new virus, you can quickly take some medicines at home for a few days so that you do not get too sick. To date, only single drugs have been approved for outpatient use against SARS-CoV-2, and we are learning that these have some limitations and may succumb to drug resistance.<\/jats:p>","DOI":"10.1128\/spectrum.03331-22","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T14:02:30Z","timestamp":1664805750000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":70,"title":["Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2"],"prefix":"10.1128","volume":"10","author":[{"given":"Jessica","family":"Wagoner","sequence":"first","affiliation":[{"name":"Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Herring","sequence":"additional","affiliation":[{"name":"Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Ying","family":"Hsiang","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Ianevski","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Biering","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Vaccinology, School of Public Health, University of California\u2014Berkeley, Berkeley, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Xu","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hoffmann","sequence":"additional","affiliation":[{"name":"Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, G\u00f6ttingen, Germany"},{"name":"Faculty of Biology and Psychology, University of G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6086-9136","authenticated-orcid":true,"given":"Stefan","family":"P\u00f6hlmann","sequence":"additional","affiliation":[{"name":"Infection Biology Unit, German Primate Center, Leibniz Institute for Primate Research, G\u00f6ttingen, Germany"},{"name":"Faculty of Biology and Psychology, University of G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Michael","family":"Gale","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0886-9769","authenticated-orcid":false,"given":"Tero","family":"Aittokallio","sequence":"additional","affiliation":[{"name":"Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland"},{"name":"Oslo Centre for Biostatistics and Epidemiology, University of Oslo and Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T.","family":"Schiffer","sequence":"additional","affiliation":[{"name":"Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"},{"name":"Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington, USA"},{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0532-996X","authenticated-orcid":true,"given":"Judith M.","family":"White","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, University of Virginia, Charlottesville, Virginia, USA"},{"name":"Department of Microbiology, University of Virginia, Charlottesville, Virginia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7475-9827","authenticated-orcid":true,"given":"Stephen J.","family":"Polyak","sequence":"additional","affiliation":[{"name":"Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA"},{"name":"Department of Global Health, University of Washington, Seattle, Washington, USA"},{"name":"Department of Microbiology, University of Washington, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035002"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2109682"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2021.12.032"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116846"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00485-0"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl7430"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2118542"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2022.03.005"},{"key":"e_1_3_3_11_2","doi-asserted-by":"crossref","unstructured":"Carlin AF Clark AE Chaillon A Garretson AF et al. 2022. Case report: virologic and immunologic characterization of COVID-19 recrudescence after nirmatrelvir\/ritonavir treatment. https:\/\/doi.org\/10.21203\/rs.3.rs-1662783\/v1. Accessed 24 May 2022.","DOI":"10.21203\/rs.3.rs-1662783\/v1"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.9925"},{"key":"e_1_3_3_13_2","doi-asserted-by":"crossref","unstructured":"Jochmans D Liu C Donckers K Stoycheva A Boland S Stevens SK De Vita C Vanmechelen B Maes P Tr\u00fceb B Ebert N Thiel V De Jonghe S Vangeel L Bardiot D Jekle A Blatt LM Beigelman L Symons JA Raboisson P Chaltin P Marchand A Neyts J Deval J Vandyck K. 2022. The substitutions L50F E166A and L167F in SARS-CoV-2 3CLpro are selected by a protease inhibitor in vitro and confer resistance to nirmatrelvir. bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2022.06.07.495116v1.","DOI":"10.1101\/2022.06.07.495116"},{"key":"e_1_3_3_14_2","doi-asserted-by":"crossref","unstructured":"Zhou Y Gammeltoft KA Ryberg LA Pham LV Fahn\u00f8e U Binderup A Hernandez CRD Offersgaard A Fernandez-Antunez C Peters GHJ Ramirez S Bukh J Gottwein JM. 2022. Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in vitro . bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2022.06.06.494921v1.","DOI":"10.1101\/2022.06.06.494921"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.77433"},{"key":"e_1_3_3_16_2","doi-asserted-by":"crossref","unstructured":"Heilmann E Costacurta F Volland A von Laer D. 2022. SARS-CoV-2 3CLpro mutations confer resistance to paxlovid (nirmatrelvir\/ritonavir) in a VSV-based non-gain-of-function system. bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2022.07.02.495455v1.","DOI":"10.1101\/2022.07.02.495455"},{"key":"e_1_3_3_17_2","doi-asserted-by":"crossref","unstructured":"Iketani S Mohri H Culbertson B Hong SJ Duan Y Luck MI Annavajhala MK Guo Y Sheng Z Uhlemann A-C Goff SP Sabo Y Yang H Chavez A Ho DD. 2022. Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir. bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2022.08.07.499047v2.","DOI":"10.1101\/2022.08.07.499047"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa232"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.03.004"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.03.004"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy304"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2016.11.017"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI89857"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01146-20"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00476-09"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009332"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.859033"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01056-22"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.12.016"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/v12101178"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13091768"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04482-x"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03347-21"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abl4784"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30163-4"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26602-3"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/veab078"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsb2104756"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30004-9"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910993"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506816"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1086\/514271"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb5883"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00754-20"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147973"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00970-21"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100849"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101169"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103856"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2901-9"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2577-1"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.3390\/v13081665"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-020-0169-8"},{"key":"e_1_3_3_55_2","doi-asserted-by":"crossref","unstructured":"Ianevski A Yao R Simonsen RM Myhre V Ravlo E Kaynova GD Zusinaite E White JM Pan Q Polyak SJ Oksenych V Windisch MP Lastauskiene E Vitkauskiene A Matukevicius A Tenson T Bjoras M Kainov DE. 2022. Broad-spectrum mono- and combinational drug therapies for global viral pandemic preparedness. bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2022.01.15.476444v2.","DOI":"10.1101\/2022.01.15.476444"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248348"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac382"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1007604"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9030566"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.3791\/57713"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071475"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-022-00618-w"},{"key":"e_1_3_3_63_2","doi-asserted-by":"crossref","unstructured":"Jeong JH Chokkakula S Min SC Kim BK Choi W-S Oh S Yun YS Kang DH Lee O-J Kim E-G Choi J-H Lee J-Y Choi YK Baek YH Song M-S. 2022. Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice. bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2022.06.27.497875v1.","DOI":"10.1101\/2022.06.27.497875"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04661-w"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-09133-9"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00128-22"},{"key":"e_1_3_3_67_2","article-title":"A phase 2 randomized, double-blind, placebo-controlled trial of oral camostat mesylate for early treatment of COVID-19 outpatients showed shorter illness course and attenuation of loss of smell and taste","author":"Chupp G","year":"2022","unstructured":"Chupp G, Spichler-Moffarah A, S\u00f8gaard OS, Esserman D, Dziura J, Danzig L, Chaurasia R, Patra KP, Salovey A, Nunez A, May J, Astorino L, Patel A, Halene S, Wang J, Hui P, Patel P, Lu J, Li F, Gan G, Parziale S, Katsovich L, Desir GV, Vinetz JM. 2022. A phase 2 randomized, double-blind, placebo-controlled trial of oral camostat mesylate for early treatment of COVID-19 outpatients showed shorter illness course and attenuation of loss of smell and taste. medRxiv. https:\/\/www.medrxiv.org\/search\/Chupp%252BG%252C%252BSpichler-Moffarah%252BA%252C%252BS%25C3%25B8gaard%252BOS.","journal-title":"medRxiv"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2108728118"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00975-21"},{"key":"e_1_3_3_70_2","first-page":"5014","article-title":"Mechanism of action of the novel anticancer agent 6-fluoro-2-(2\u2032-fluoro-1,1\u2032-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis","volume":"46","author":"Chen SF","year":"1986","unstructured":"Chen SF, Ruben RL, Dexter DL. 1986. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2\u2032-fluoro-1,1\u2032-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis. Cancer Res 46:5014\u20135019.","journal-title":"Cancer Res"},{"key":"e_1_3_3_71_2","doi-asserted-by":"crossref","unstructured":"Demarest JF Kienle M Boytz R Ayres M Kim EJ Chung D Gandhi V Davey R Sykes DB Shohdy N Pottage JC Kumar VS. 2022. Brequinar and dipyridamole in combination exhibits synergistic antiviral activity against SARS-CoV-2 in vitro : rationale for a host-acting antiviral treatment strategy for COVID-19. bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2022.03.30.486499v2.","DOI":"10.1101\/2022.03.30.486499"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104448"},{"key":"e_1_3_3_73_2","doi-asserted-by":"crossref","unstructured":"Nguyenla X Wehri E Van Dis E Biering SB Yamashiro LH Stroumza J Dugast-Darzacq C Graham T Stanley S Schaletzky J. 2020. Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells. bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2020.09.18.302398v1.","DOI":"10.1101\/2020.09.18.302398"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2422"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2713"},{"key":"e_1_3_3_76_2","doi-asserted-by":"crossref","unstructured":"Moghadasi SA Heilmann E Moraes SN Kearns FL von Laer D Amaro RE Harris RS. 2022. Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors. bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2022.08.07.503099v1.","DOI":"10.1101\/2022.08.07.503099"},{"key":"e_1_3_3_77_2","doi-asserted-by":"crossref","unstructured":"Hu Y Lewandowski EM Tan H Morgan RT Zhang X Jacobs LMC Butler SG Mongora MV Choy J Chen Y Wang J. 2022. Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir. bioRxiv. https:\/\/www.biorxiv.org\/content\/10.1101\/2022.06.28.497978v2.","DOI":"10.1101\/2022.06.28.497978"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009929"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00198-22"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1800050\/v1"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109450"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2649"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.03331-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.03331-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T18:27:47Z","timestamp":1670005667000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.03331-22"}},"subtitle":[],"editor":[{"given":"Miguel Angel","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10,26]]}},"alternative-id":["10.1128\/spectrum.03331-22"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.03331-22","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]},"assertion":[{"value":"2022-09-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e03331-22"}}